Authors: Thomas Brion1, Eleni Karamouza2, Louis De Vitry3, Aurélien Lombard3, Thais Roque3, Nikos Paragios3, Guillaume Auzac1, Assia Lamrani-Ghaouti4, Naïma Bonnet4, Elaine Limkin1, Marjolaine Ung1, Sophie Bockel1, David Pasquier5, Stéphanie Wong6, HypoG-01 trialists4, Samir Achkar1, Sofia Rivera7,1
1Institut Gustave Roussy, Radiation Oncology, Villejuif, France; 2Institut Gustave Roussy, Biostatistics and Epidemiology, Villejuif, France; 3Therapanacea, Artificial Intelligence, Paris, France; 4Unicancer, Unitrad, Kremlin Bicêtre, France; 5Centre Oscar Lambret, Radiation Oncology, Lille, France; 6Assistance Publique des Hôpitaux de Marseille, Radiation Oncology, Marseille, France; 7Université Paris - Saclay, INSERM U1030, Villejuif, France
Show Affiliations
Hide Affiliations